LRG-1 promotes pancreatic cancer growth and metastasis via modulation of the EGFR/p38 signaling
Abstract Background The abnormal expression of leucine-rich-alpha-2-glycoprotein 1 (LRG-1) is reported to be associated with multiple malignancies, but its role in the progression of pancreatic ductal adenocarcinoma (PDAC) remains to be determined. Methods The expression of LRG-1 was assessed in PDA...
Main Authors: | Zhi-Bo Xie, Yi-Fan Zhang, Chen Jin, Yi-Shen Mao, De-Liang Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-02-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13046-019-1088-0 |
Similar Items
-
Oxidative stress induces monocyte‐to‐myofibroblast transdifferentiation through p38 in pancreatic ductal adenocarcinoma
by: Xin Huang, et al.
Published: (2020-06-01) -
Diagnostic accuracy of Leucine-rich α-2 glycoprotein (LRG) as a urinary biomarker in pediatric appendicitis: a prospective observational pilot study from Eastern India
by: Santosh Kumar Mahalik, et al.
Published: (2021-06-01) -
The EGFR-HSF1 axis accelerates the tumorigenesis of pancreatic cancer
by: Weikun Qian, et al.
Published: (2021-01-01) -
LRG1: an emerging player in disease pathogenesis
by: Carlotta Camilli, et al.
Published: (2022-01-01) -
LRG1 predicts the prognosis and is associated with immune infiltration in thyroid cancer: a bioinformatics study
by: Zherui Fu, et al.
Published: (2023-12-01)